Recombinant Humanized Anti-interleukin-6 Receptor Monoclonal Antibody Injection

BIOLOGICAL2 trials

Sponsors

Beijing VDJBio Co., LTD.

Conditions

Anti IL-6RRheumatoid ArthritisRheumatoid Arthritis (RA)

Phase 2

Phase II Trial of VDJ001 in Patients With Moderate-to-severe Active Rheumatoid Arthritis

CompletedNCT05957107

Beijing VDJBio Co., LTD.Rheumatoid Arthritis

Start: 2022-05-26End: 2023-06-02Updated: 2025-07-09

Phase 3

Phase III Trial of VDJ001 In Patients With Moderate-to-severe Active Rheumatoid Arthritis

Enrolling by invitationNCT06726096

Beijing VDJBio Co., LTD.Anti IL-6R, Rheumatoid Arthritis (RA)

Start: 2025-04-09End: 2026-12-31Target: 615Updated: 2025-08-11